Increased phosphorylation of the renal Na+-Cl- cotransporter in male kidney transplant recipient patients with hypertension: A prospective cohort

American Journal of Physiology - Renal Physiology

Volumn 309, Issue 10, 2015, Pages F836-F842

  Rojas Vega, Lorena ^a,b   Jiménez Vega, Aldo R ^a   Bazúa Valenti, Silvana ^a,b   Arroyo Garza, Isidora ^a   Jiménez, José Victor ^a,b   Gómez Ocádiz, Ruy ^a   Carrillo Pérez, Diego Luis ^a   Moreno, Erika ^a   Morales Buenrostro, Luis E ^a   Alberú, Josefina ^a   Gamba, Gerardo ^a,b  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Calcineurin inhibitors; Diuretics; Renal transplantation; Salt transport; Tacrolimus

Indexed keywords

MYCOPHENOLATE MOFETIL; SODIUM CHLORIDE COTRANSPORTER; STEROID; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BODY WEIGHT; COHORT ANALYSIS; CONTROLLED STUDY; END STAGE RENAL DISEASE; EXOSOME; FEMALE; GRAFT RECIPIENT; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; AGED; BLOOD PRESSURE; DRUG EFFECTS; KIDNEY; METABOLISM; MIDDLE AGED; PHOSPHORYLATION; PROCEDURES; SEX DIFFERENCE;

ADULT; AGED; BLOOD PRESSURE; COHORT STUDIES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PHOSPHORYLATION; PROSPECTIVE STUDIES; SEX FACTORS; SOLUTE CARRIER FAMILY 12, MEMBER 3; TACROLIMUS;

EID: 84947206313     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00326.2015     Document Type: Article

References (33)

1. Boyden LM, Choi M, Choate KA, Nelson-Williams CJ, Farhi A, Toka HR, Tikhonova IR, Bjornson R, Mane SM, Colussi G, Lebel M, Gordon RD, Semmekrot BA, Poujol A, Valimaki MJ, De Ferrari ME, Sanjad SA, Gutkin M, Karet FE, Tucci JR, Stockigt JR, Keppler- Noreuil KM, Porter CC, Anand SK, Whiteford ML, Davis ID, Dewar SB, Bettinelli A, Fadrowski JJ, Belsha CW, Hunley TE, Nelson RD, Trachtman H, Cole TR, Pinsk M, Bockenhauer D, Shenoy M, Vaidyanathan P, Foreman JW, Rasoulpour M, Thameem F, Al Shahrouri HZ, Radhakrishnan J, Gharavi AG, Goilav B, Lifton RP. Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature 482: 98–102, 2012
2. Castagna A, Pizzolo F, Chiecchi L, Morandini F, Channavajjhala S, Guarini P, Salvagno G, Olivieri O. Circadial exosomal expression of renal thiazide-sensitive NaCl cotransporter (NCC) and prostasin in healthy individuals. Proteomics Clin Appl 9: 623–629, 2015
3. + intake: insights into the signaling pathways involved. Am J Physiol Renal Physiol 306: F1507–F1519, 2014
4. Corbetta S, Raimondo F, Tedeschi S, Syren ML, Rebora P, Savoia A, Baldi L, Bettinelli A, Pitto M. Urinary exosomes in the diagnosis of Gitelman and Bartter syndromes. Nephrol Dial Transp 30: 621–630, 2015
5. Dear JW, Street JM, Bailey MA. Urinary exosomes: a reservoir for biomarker discovery and potential mediators of intrarenal signalling. Proteomics 13: 1572–1580, 2013
6. Esteva-Font C, Guillen-Gomez E, Diaz JM, Guirado L, Facundo C, Ars E, Ballarin JA, Fernandez-Llama P. Renal sodium transporters are increased in urinary exosomes of cyclosporine-treated kidney transplant patients. Am J Nephrol 39: 528–535, 2014
7. Frist WH, Stinson EB, Oyer PE, Baldwin JC, Shumway NE. Longterm hemodynamic results after cardiac transplantation. J Thor Cardiovas Surg 94: 685–693, 1987
8. Gardiner SM, March JE, Kemp PA, Fallgren B, Bennett T. Regional haemodynamic effects of cyclosporine A, tacrolimus and sirolimus in conscious rats. Br J Pharmacol 141: 634–643, 2004
9. Hoorn EJ, Walsh SB, McCormick JA, Furstenberg A, Yang CL, Roeschel T, Paliege A, Howie AJ, Conley J, Bachmann S, Unwin RJ, Ellison DH. The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension. Nat Med 17: 1304–1309, 2011
10. Lazelle R, McCully B, Yang CL, Ellison DH. FKBP12 kidney-specific knockout mice are protected from tacrolimus-induced hypertension. FASEB J 29: 811. 811, 2015
11. Louis-Dit-Picard H, Barc J, Trujillano D, Miserey-Lenkei S, Bouatia- Naji N, Pylypenko O, Beaurain G, Bonnefond A, Sand O, Simian C, Vidal-Petiot E, Soukaseum C, Mandet C, Broux F, Chabre O, Delahousse M, Esnault V, Fiquet B, Houillier P, Bagnis CI, Koenig J, Konrad M, Landais P, Mourani C, Niaudet P, Probst V, Thauvin C, Unwin RJ, Soroka SD, Ehret G, Ossowski S, Caulfield M, Bruneval P, Estivill X, Froguel P, Hadchouel J, Schott JJ, Jeunemaitre X. KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron. Nat Genet 44: 456–460, 2012
12. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F; Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 31: 1281–1357, 2013
13. Mange KC, Cizman B, Joffe M, Feldman HI. Arterial hypertension and renal allograft survival. JAMA 283: 633–638, 2000
14. Mange KC, Feldman HI, Joffe MM, Fa K, Bloom RD. Blood pressure and the survival of renal allografts from living donors. J Am Soc Nephrol 15: 187–193, 2004
15. Mayan H, Attar-Herzberg D, Shaharabany M, Holtzman EJ, Farfel Z. Increased urinary Na-Cl cotransporter protein in familial hyperkalaemia and hypertension. Nephrol Dial Transp 23: 492–496, 2008
16. Mayan H, Vered I, Mouallem M, Tzadok-Witkon M, Pauzner R, Farfel Z. Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density. J Clin Endocrinol Metab 87: 3248–3254, 2002
17. Melnikov S, Mayan H, Uchida S, Holtzman EJ, Farfel Z. Cyclosporine metabolic side effects: association with the WNK4 system. Eur J Clin Invest 41: 113–1120, 2011
18. Morales JM, Dominguez-Gil B. Impact of tacrolimus and mycophenolate mofetil combination on cardiovascular risk profile after kidney transplantation. J Am Soc Nephrol 17: S296–S303, 2006
19. Pacheco-Alvarez D, San Cristobal P, Meade P, Moreno E, Vazquez N, Munoz E, Diaz A, Juarez ME, Gimenez I, Gamba G. The Na-Cl cotransporter is activated and phosphorylated at the amino terminal domain upon intracellular chloride depletion. J Biol Chem 281: 28755–28763, 2006
20. Pisitkun T, Shen RF, Knepper MA. Identification and proteomic pro- filing of exosomes in human urine. Proc Natl Acad Sci USA 101: 13368–13373, 2004
21. - cotransporter by the WNK-regulated kinases SPAK and OSR1. J Cell Sci 121: 675–684, 2008
22. Robert N, Wong GW, Wright JM. Effect of cyclosporine on blood pressure. Cochrane Database Syst Rev CD007893, 2010
23. Rojas-Vega L, Reyes-Castro LA, Ramirez V, Bautista-Perez R, Rafael C, Castaneda-Bueno M, Meade P, de Los Heros P, Arroyo-Garza I, Bernard V, Binart N, Bobadilla NA, Hadchouel J, Zambrano E, Gamba G. Ovarian hormones and prolactin increase renal NaCl cotransporter phosphorylation. Am J Physiol Renal Physiol 308: F799–F808, 2015
24. Simon DB, Nelson-Williams C, Johnson-Bia M, Ellison D, Karet FE, Morey-Molina A, Vaara I, Iwata F, Cushner HM, Koolen M, Gainza FJ, Gitelman HJ, Lifton RP. Gitelman’s variant of Bartter’s syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazidesensitive Na-Cl cotransporter. Nat Genet 12: 24–30, 1996
25. Suthanthiran M, Strom TB. Renal transplantation. New Engl J Med 331: 365–376, 1994
26. Taber DJ, Srinivas TM, Pilch NA, Meadows HB, Fleming JN, McGillicuddy JW, Bratton CF, Thomas B, Chavin KD, Baliga PK, Egede LE. Are thiazide diuretics safe and effective antihypertensive therapy in kidney transplant recipients? Am J Nephrol 38: 285–291, 2013
27. Textor SC, Canzanello VJ, Taler SJ, Wilson DJ, Schwartz LL, Augustine JE, Raymer JM, Romero JC, Wiesner RH, Krom RA, Burnett JC. Cyclosporine-induced hypertension after transplantation. Mayo Clin Proc 69: 1182–1193, 1994
28. van der Lubbe N, Jansen PM, Salih M, Fenton RA, van den Meiracker AH, Jan Danser AH, Zietse R, Hoorn EJ. The phosphorylated sodium chloride cotransporter in urinary exosomes is superior to prostasin as a marker for aldosteronism. Hypertension 60: 741–748, 2012
29. Verghese PS, Dunn TB, Chinnakotla S, Gillingham KJ, Matas AJ, Mauer MS. Calcineurin inhibitors in HLA-identical living related donor kidney transplantation. Nephrol Dial Transp 29: 209–218, 2014
30. Weir MR, Burgess ED, Cooper JE, Fenves AZ, Goldsmith D, McKay D, Mehrotra A, Mitsnefes MM, Sica DA, Taler SJ. Assessment and management of hypertension in transplant patients. J Am Soc Nephrol 26: 1248–1260, 2015
31. Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson- Williams C, Desitter I, Gunel M, Milford DV, Lipkin GW, Achard JM, Feely MP, Dussol B, Berland Y, Unwin RJ, Mayan H, Simon DB, Farfel Z, Jeunemaitre X, Lifton RP. Human hypertension caused by mutations in WNK kinases. Science 293: 1107–1112, 2001
32. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, Held PJ, Port FK. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. New Engl J Med 341: 1725–1730, 1999
33. Zhou H, Yuen PS, Pisitkun T, Gonzales PA, Yasuda H, Dear JW, Gross P, Knepper MA, Star RA. Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery. Kidney Int 69: 1471–1476, 2006.